Pfizer (NYSE:PFE) has been dismissed as a defendant in a major federal lawsuit alleging generic drug price fixing. The court ...

Pfizer has successfully warded off three drug manufacturers from placing generics referencing Vyndamax (tafamidis) on the US market, though the countdown to the blockbuster’s loss of exclusivity ...

Pfizer Inc. was able to dodge litigation alleging it colluded with other pharmaceutical companies to fix the price of generic ...

Pfizer Inc has agreed to pay $190 million to settle a class action lawsuit alleging the pharmaceutical company took steps to delay market entry of generic versions of its epilepsy drug Neurontin, ...

Patients taking Pfizer’s Vyndaqel and Vyndamax for a progressive, often fatal form of heart failure will not see cheaper generic alternatives on pharmacy shelves until at least 2031. Pfizer has ...

Pfizer recently filed at least seven lawsuits in federal court seeking to enjoin multiple multinational pharmaceutical companies from selling a generic version of its medication, Nurtec, which is used ...

TORONTO/NEW YORK (Reuters) - Apotex Inc said on Wednesday it would immediately launch in Canada a copycat form of Pfizer Inc's blockbuster Lipitor cholesterol fighter, and Pfizer vowed to fight back ...